1st International Conference on Artificial Intelligence in Oncology

ICAIO 2025

Date February 26, 2025

Format Hybrid

Venue Vishwakarma University, Pune, Maharashtra, India

Website icaio.vupune.ac.in

Overview

WUST Co-Organizes a Landmark Conference at the Intersection of AI and Cancer Research

Washington University of Science and Technology (WUST) was proud to serve as a co-organizing partner of the 1st International Conference on Artificial Intelligence in Oncology (ICAIO 2025), a landmark academic event that brought together world-class researchers, clinicians, and technology leaders to advance the application of artificial intelligence in the fight against cancer.

ICAIO 2025 was organized by the Faculty of Science and Technology in collaboration with Washington University of Science and Technology, USA, and the Research Cell of Vishwakarma University, Pune. This three-way international partnership reflected WUST's commitment to building bridges between academia, clinical medicine, and cutting-edge technology, across institutions, disciplines, and continents.

About the Conference

The integration of Artificial Intelligence into oncology has opened new frontiers in the diagnosis, treatment, and management of cancer. With advancements in machine learning, deep learning, and data analytics, AI has the potential to transform clinical practices, improve patient outcomes, and accelerate cancer research. The International Conference on Artificial Intelligence in Oncology 2025 aimed to bring together world-renowned experts, researchers, clinicians, and technology leaders to explore the latest AI-driven innovations in oncology.

Hybrid Format

ICAIO 2025 was structured as a hybrid conference, allowing both in-person and virtual participation, ensuring maximum accessibility for researchers and clinicians from across the globe.

Conference Objectives

The main objectives of ICAIO 2025 were:

Explore cutting-edge AI technologies by showcasing AI innovations in early detection, diagnostics, treatment planning, and personalized medicine in oncology
Foster collaboration between AI researchers, oncologists, bioinformaticians, and healthcare professionals
Discuss ethical and regulatory challenges around AI implementation, data privacy, and healthcare regulations in oncology
Promote AI in cancer research by presenting the latest breakthroughs in cancer genomics, clinical trials, and drug discovery powered by AI
Provide networking opportunities to facilitate partnerships, collaborations, and future projects in AI and oncology

Research Tracks

ICAIO 2025 was organized into five focused research tracks, each addressing a distinct dimension of AI's role in oncology:

Track 1: AI in Basic Principles of Oncology

This track focused on the intersection of artificial intelligence and the foundational principles of oncology, exploring how AI technologies can enhance understanding of cancer biology, pathophysiology, and fundamental mechanisms of tumorigenesis, highlighting AI's contributions to unraveling the complexity of cancer biology and improving understanding of tumor development, progression, and heterogeneity.

Track 2: AI in Public Health

This track explored how AI technologies can enhance population-based cancer control, improve the efficiency and accessibility of healthcare services, and reduce cancer-related disparities, with a focus on AI's transformative role in prevention, early detection, and cancer management, particularly in resource-limited settings.

Track 3: AI in Solid Malignancies

Covering cancers such as breast, lung, colorectal, and prostate, this track explored AI's integration into the management of solid tumors, with a focus on diagnostics, treatment decision-making, predictive modeling, and therapeutic developments in some of the leading causes of cancer-related morbidity and mortality worldwide.

Track 4: AI in Hematological Malignancies

Focusing on leukemia, lymphoma, and myeloma, this track examined how AI technologies are being leveraged to improve early detection, personalize treatment plans, predict treatment responses, and monitor disease progression in hematological cancers, with emphasis on genomic profiling and clinical trial optimization.

Track 5: AI in Special Topics in Oncology

This track explored the emerging frontiers of AI in oncology, covering rare cancers, immunotherapy, cancer prevention, AI in palliative care, AI-driven healthcare optimization, and novel AI applications in multi-disciplinary approaches to cancer treatment, bringing together experts to promote innovation and foster collaboration in these specialized areas.

Invited Speakers

ICAIO 2025 featured internationally recognized experts from the fields of oncology, clinical medicine, and artificial intelligence:

Dr. Sachi Nandan Mohanty Professor, VIT AP, Amaravati, Andhra Pradesh, India

Dr. Jayant Sastri Goda Professor and Clinician Scientist, Radiation Oncology ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai, India

Dr. Abhay Somani Senior Interventional Cardiologist, Ruby Hall Clinic, Pune, India

Dr. Dharanidhar Dang Assistant Professor, University of Texas, San Antonio, Texas, USA

Publication

Springer Nature Proceedings - Scopus Indexed

All accepted full-length papers from ICAIO 2025 were published in Springer Nature Proceedings, which is Scopus indexed. This publication pathway ensures that research presented at ICAIO 2025 reaches the widest possible international academic audience and carries the full weight of peer-reviewed, indexed scholarly recognition, a standard that directly benefits WUST-affiliated researchers whose work was presented and published through this conference.

WUST's Role and Significance

WUST's co-organization of ICAIO 2025 reflects the university's broader commitment to multidisciplinary research at the intersection of technology and human health. Artificial intelligence and its application to real-world problems, including some of the most pressing challenges in global healthcare, sit squarely within the mission of WUST's Institute for Digital Innovation and Center for Research.

For WUST, ICAIO 2025 was more than a conference. It was a demonstration that a university built on the principles of Degree. Skill. Career. can contribute meaningfully to conversations that matter at the highest levels of global science, connecting its faculty, students, and institutional partners to a field where the stakes are nothing less than human lives.

Partner Institution

Vishwakarma University, Pune

Vishwakarma University, Pune is a State Private University established through Maharashtra Government Act in 2017, UGC approved, and ranked among the top institutions from 98 countries in the Times Higher Education Global Impact Rankings 2021, which assess universities against the United Nations' Sustainable Development Goals. WUST's partnership with Vishwakarma University reflects a shared commitment to excellence, innovation, and the responsible advancement of technology in service of society.

Visit Official Conference Website →